Stock listing
NASDAQ:VERA Vera Therapeutics, Inc. Stock
Home listing (NASDAQ) of Vera Therapeutics, Inc.
Follow Vera Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:VERA
$29.04 USD -1.44 (-4.7%)
Close on Nov 12, 2026
- Day range
- $28.83 – $30.46 USDNov 12, 2026
- Volume
- 912,716 sharesNov 12, 2026
- Market cap
- $2.09B USDAt the close on Nov 12, 2026 · price × 72.06M shares outstanding
- 52-week range
- $26.38 – $56.05 USDLowest and highest trades, Nov 13, 2025 – Nov 12, 2026
- Traded on an average day
- $65.41M USDMedian day 1.65M shares · last 3 months, Aug 12, 2026 – Nov 12, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VERA · Home | $29.04 USD | -1.44 (-4.7%) | 912,716 | $30.10 | $30.46 | $28.83 | $30.48 | Close on Nov 12, 2026 |
Daily closes
Last 3 months, Aug 12, 2026 – Nov 12, 2026 · NASDAQ:VERA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $29.04 | -1.44 | -4.7% | $30.10 | $30.46 | $28.83 | 912,716 | |
| $30.48 | +0.45 | +1.5% | $30.17 | $30.62 | $29.81 | 1,710,187 | |
| $30.03 | -0.58 | -1.9% | $30.20 | $31.07 | $29.80 | 1,851,785 | |
| $30.61 | +0.825 | +2.8% | $30.40 | $30.90 | $28.86 | 1,392,016 | |
| $29.79 | -0.355 | -1.2% | $30.48 | $30.84 | $28.04 | 2,078,168 | |
| $30.14 | -1.83 | -5.7% | $31.55 | $32.15 | $30.07 | 1,417,373 | |
| $31.97 | +1.26 | +4.1% | $31.00 | $32.18 | $30.73 | 1,881,317 | |
| $30.71 | +0.46 | +1.5% | $30.26 | $31.19 | $29.90 | 1,578,039 | |
| $30.25 | -0.73 | -2.4% | $31.05 | $32.78 | $30.23 | 2,111,134 | |
| $30.98 | +0.45 | +1.5% | $30.30 | $31.29 | $29.56 | 1,083,959 | |
| $30.53 | -0.41 | -1.3% | $31.29 | $31.91 | $30.36 | 1,107,286 | |
| $30.94 | +0.95 | +3.2% | $29.77 | $31.13 | $29.77 | 1,277,484 | |
| $29.99 | +1.69 | +6.0% | $28.35 | $30.02 | $28.21 | 1,068,616 | |
| $28.30 | +0.31 | +1.1% | $27.94 | $28.46 | $27.56 | 1,170,797 | |
| $27.99 | -1.06 | -3.6% | $28.75 | $29.44 | $27.46 | 1,982,000 | |
| $29.05 | -2.15 | -6.9% | $30.99 | $31.84 | $28.71 | 2,545,600 | |
| $31.20 | +1.14 | +3.8% | $30.01 | $31.57 | $29.85 | 2,083,600 | |
| $30.06 | +1.14 | +3.9% | $28.92 | $30.52 | $28.87 | 1,189,500 | |
| $28.92 | +1.04 | +3.7% | $28.20 | $29.24 | $27.61 | 1,268,900 | |
| $27.88 | -0.69 | -2.4% | $28.30 | $28.40 | $27.50 | 1,294,200 | |
| $28.57 | +1.83 | +6.8% | $27.28 | $28.83 | $27.13 | 1,526,500 | |
| $26.74 | -0.05 | -0.2% | $26.85 | $27.42 | $26.38 | 1,534,600 | |
| $26.79 | -0.93 | -3.4% | $27.62 | $27.73 | $26.55 | 2,990,400 | |
| $27.72 | -2.16 | -7.2% | $29.11 | $29.49 | $27.64 | 1,405,300 | |
| $29.88 | +0.15 | +0.5% | $29.57 | $30.51 | $29.46 | 996,600 | |
| $29.73 | -0.52 | -1.7% | $30.00 | $30.25 | $28.74 | 1,731,300 | |
| $30.25 | +0.83 | +2.8% | $29.09 | $30.61 | $28.46 | 3,285,100 | |
| $29.42 | -0.41 | -1.4% | $29.98 | $30.10 | $28.37 | 2,395,800 | |
| $29.83 | -0.59 | -1.9% | $30.58 | $30.74 | $28.79 | 2,715,100 | |
| $30.42 | -0.57 | -1.8% | $31.16 | $31.27 | $29.80 | 1,614,800 | |
| $30.99 | -1.30 | -4.0% | $32.14 | $32.44 | $30.87 | 1,009,500 | |
| $32.29 | -0.085 | -0.3% | $32.57 | $33.60 | $32.20 | 1,799,900 | |
| $32.38 | -0.125 | -0.4% | $32.50 | $32.84 | $31.90 | 1,457,500 | |
| $32.50 | -0.04 | -0.1% | $32.34 | $33.04 | $31.42 | 1,464,600 | |
| $32.54 | -0.80 | -2.4% | $33.34 | $33.44 | $32.46 | 1,250,500 | |
| $33.34 | +0.29 | +0.9% | $32.72 | $33.68 | $32.23 | 1,691,400 | |
| $33.05 | -3.21 | -8.9% | $36.27 | $36.50 | $32.63 | 2,017,900 | |
| $36.26 | +2.01 | +5.9% | $34.67 | $36.50 | $34.30 | 1,977,600 | |
| $34.25 | +0.25 | +0.7% | $34.50 | $34.98 | $33.65 | 1,234,600 | |
| $34.00 | -0.27 | -0.8% | $34.56 | $34.56 | $33.08 | 4,190,800 | |
| $34.27 | +2.50 | +7.9% | $32.50 | $36.23 | $32.50 | 3,881,400 | |
| $31.77 | -1.90 | -5.6% | $33.22 | $34.00 | $31.19 | 3,910,400 | |
| $33.67 | -0.38 | -1.1% | $37.14 | $37.14 | $32.73 | 10,491,300 | |
| $34.05 | -1.00 | -2.9% | $35.11 | $35.54 | $33.22 | 1,705,500 | |
| $35.05 | +1.45 | +4.3% | $33.91 | $35.29 | $33.75 | 3,796,700 | |
| $33.60 | -0.18 | -0.5% | $33.49 | $34.29 | $32.88 | 2,027,500 | |
| $33.78 | -1.50 | -4.3% | $34.84 | $35.48 | $33.75 | 938,300 | |
| $35.28 | -0.61 | -1.7% | $35.80 | $36.00 | $34.89 | 1,442,800 | |
| $35.89 | +0.90 | +2.6% | $34.69 | $36.41 | $34.69 | 1,184,600 | |
| $34.99 | -0.67 | -1.9% | $35.53 | $35.74 | $34.53 | 929,000 | |
| $35.66 | +1.43 | +4.2% | $34.44 | $35.73 | $33.81 | 1,756,500 | |
| $34.23 | +0.15 | +0.4% | $33.73 | $34.40 | $33.65 | 4,070,000 | |
| $34.08 | -0.11 | -0.3% | $33.64 | $34.38 | $33.18 | 1,536,700 | |
| $34.19 | -0.41 | -1.2% | $34.40 | $34.47 | $33.34 | 1,256,500 | |
| $34.60 | -2.22 | -6.0% | $36.70 | $36.70 | $34.10 | 2,781,800 | |
| $36.82 | +1.54 | +4.4% | $35.10 | $36.96 | $34.64 | 2,378,300 | |
| $35.28 | +1.56 | +4.6% | $34.05 | $35.57 | $34.00 | 2,488,200 | |
| $33.72 | +1.445 | +4.5% | $32.25 | $35.09 | $32.02 | 2,409,600 | |
| $32.28 | +1.015 | +3.2% | $31.42 | $32.97 | $31.03 | 1,288,100 | |
| $31.26 | -1.015 | -3.1% | $32.30 | $32.30 | $30.72 | 1,563,900 | |
| $32.28 | -0.005 | 0.0% | $32.88 | $33.48 | $31.70 | 1,259,600 | |
| $32.28 | +0.65 | +2.1% | $31.31 | $32.35 | $31.31 | 1,033,600 | |
| $31.63 | 0.00 | 0.0% | $31.30 | $32.72 | $31.10 | 2,748,800 | |
| $31.63 | +2.74 | +9.5% | $31.29 | $32.31 | $29.73 | 5,875,800 | |
| $28.89 | -1.10 | -3.7% | $29.99 | $30.11 | $28.86 | 1,167,700 | |
| $29.99 | -0.30 | -1.0% | $30.74 | $31.18 | $29.71 | 1,676,400 |
- Ticker
- NASDAQ:VERA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 6, 2026
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Latest earnings call · Nov 5, 2026
Vera Therapeutics (NASDAQ:VERA) Q3 2026 Earnings Call
Replay and transcript
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 34 slides
Calls
Replays
Vera Therapeutics (NASDAQ:VERA) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 6, 2026
Closed $30.61 (+2.8%) on Nov 9, 2026
Vera Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results
Nov 5, 2026
Closed $29.79 (-1.2%) on Nov 6, 2026
Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
Nov 2, 2026
Closed $30.25 (-2.4%) on Nov 2, 2026
Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of Medicine
Oct 22, 2026
Closed $29.05 (-6.9%) on Oct 22, 2026
Vera Therapeutics to Host ASN Kidney Week Investor Webcast and Third Quarter 2026 Financial Results Conference Webcast
Oct 20, 2026
Closed $30.06 (+3.9%) on Oct 20, 2026
Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking Oral Presentation at the Opening Plenary Session of ASN Kidney Week 2026
Oct 2, 2026
Closed $30.42 (-1.8%) on Oct 2, 2026
Vera Therapeutics Announces TRUTAKNA Stabilized eGFR and Prevented Kidney Disease Progression through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy
Sep 16, 2026
Closed $31.77 (-5.6%) on Sep 16, 2026
Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
Aug 10, 2026
Closed $30.29 (-4.1%) on Aug 11, 2026
Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner
Jul 9, 2026
Closed $42.45 (0.0%) on Jul 9, 2026
Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy
Jul 7, 2026
Closed $42.96 (+7.1%) on Jul 7, 2026
Financings
Public offering of class A common stock
Dec 9, 2025
Announced: about US$261M · US$42.5 a share · J.P. Morgan +4
Dealers: LifeSci Capital (lead), J.P. Morgan (co-lead), Goldman Sachs & Co. LLC (co-lead), Evercore ISI (co-lead), Cantor (co-lead)
Decks
Investor Presentation (November 2026)
Investor deck · 34 slides · November 2026
Investor Presentation (October 2026)
Investor deck · 28 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 32 slides · September 2026
Investor Presentation (November 2025)
Investor deck · 6 slides · Nov 6, 2025
Vera Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 27 in the last 12 months · 125 in all · newest Nov 6, 2026 · oldest 2021
- Calls
- 1 call with a replay · 1 with a transcript · latest Nov 5, 2026
- Decks
- 17 decks · latest November 2026
Where Vera Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VERA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:VERA | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Vera Therapeutics, Inc.